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a  b  s  t  r  a  c  t
Iron  oxide  nanoparticles  (INPs)  have  potential  biological,  biomedical  and  environmental
applications.  These  applications  require  surface  modiﬁcation  of  the  iron  oxide  nanoparti-
cles,  which  makes  it non-toxic,  biocompatible,  stable  and  non-agglomerative  in  natural  and
biological  surroundings.  In the  present  study,  iron  oxide  nanoparticles  (INPs)  and  chitosan
oligosaccharide  coated  iron  oxide  nanoparticles  (CSO-INPs)  were  synthesized  to evaluate
the effect  of  surface  coating  on  the  stability  and  toxicity  of nanoparticles.  Comparative
in  vitro  cytotoxicity  of  nanoparticles  was  evaluated  in  HeLa  (human  cervix  carcinoma),
A549  (human  lung  carcinoma)  and  Hek293  (human  embryonic  kidney)  cells  by  using  3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide  (MTT)  assay  along  with  ﬂow
cytometry  study  for  cell  viability,  membrane  integrity,  mitochondrial  membrane  potential
(MMP) and  reactive  oxygen  species  (ROS)  production.  Morphological  alteration  in  nanopar-
ticles treated  cells  was  analyzed  by Acridine  orange/ethidium  bromide  double  staining  and
electron microscopy.  Synthesized  nanoparticles  were  found  to be spherical  in shape,  well
dispersed and  stable  at various  pH  values,  making  them  suitable  for biomedical  and  envi-
ronmental  applications.  The  present  study  also  indicates  that  the chitosan  oligosaccharide
coating  on  iron  oxide  nanoparticles  results  in  the  decrease  in  cellular  damage  and  moderate
ROS production,  thereby,  signiﬁcantly  decreasing  the  cytotoxic  impact  of  bare  iron  oxide
nanoparticles.
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Y-NC-N©  2014  Publ
B
. IntroductionNanoscience has emerged as an innovative research
eld having application in a number of scientiﬁc and tech-
ological areas, including materials science, electronics,
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biotechnology and medical sciences [1]. Nanomaterials can
be found in more than 1000 consumer products includ-
ing electronic components, cosmetics, antimicrobial and
stain-resistant fabric cleaning products [2,3]. Among the
nanostructured materials, metallic nanoparticles in par-
ticular, iron oxide nanoparticles have been the focus of
intensive research. Magnetic iron oxide nanoparticles have
potential applications in various disciplines of science
ranging from environmental remediation to biomedical
such as magnetic drug targeting, tissue repair, and cell tis-
sue targeting [4].
e under the CC BY-NC-ND license
28 S. Shukla et al. / Toxicology Reports 2 (2015) 27–39
 of chitoFig. 1. TEM image of iron oxide nanoparticles (INPs) (a). TEM image
Magnetic iron oxide nanoparticles with a bare surface
tend to agglomerate because of strong magnetic attrac-
tions among the particles. Stabilizers such as carboxylates,
inorganic compounds and polymeric compounds have
functional groups to modify these particles and enhance
its stability [5,6]. Among the various polymers, chitosan an
alkaline product of chitin has been widely examined due
to its hydrophilicity, biocompatibility and biodegradability
[7,8]. Chemically chitosan is insoluble in water and behaves
as a weak base making it inappropriate for biological and
environmental applications. On the other hand, chitosan
oligosaccharides, which can be produced by degradation of
chitosan polymer chain, are water soluble making it suit-
able for biological and environmental applications [9].Previous studies have highlighted the potential envi-
ronmental and health hazards caused by nanomaterials
[10–13]. Nanoscale properties such as high surface to
Fig. 2. X-ray diffraction (XRD) pattern of iron oxide nanoparticles (INPs) (a). X-ra
nanoparticles (CSO-INPs) (b).san oligosaccharide coated iron oxide nanoparticles (CSO-INP) (b).
volume ratio, high surface energy, and higher surface
reactivity may  imperil human health through cytotoxic
and genotoxic effects [13].
Nanomaterials can enter the human body through
dermal absorption, respiratory inhalation, or oral route.
Due to their ultraﬁne size, they are able to move across
the olfactory mucosa, alveolar membrane and capillary
endothelium. The ability of nanomaterials to cross blood
brain barrier enhances its toxicity for the nervous system
[14].
There is an urgent need for understanding the potential
risks associated with iron oxide nanoparticles along with
the range of surface coatings utilized for its functionality
[15–17]. Earlier published reports corroborate the proba-
ble mechanism of internalization and interaction of iron
oxide nanoparticles with various cellular targets mainly
mitochondria, nucleus and DNA [18,19].
y diffraction (XRD) pattern of chitosan oligosaccharide coated iron oxide
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lig. 3. Fourier transform infrared (FTIR) spectroscopy characteristic peaks
f iron oxide nanoparticles (INPs) (a). FTIR characteristic peaks of chitosan
ligosaccharide coated iron oxide nanoparticles (CSO-INPs) (b).
In this study, bare iron oxide nanoparticles and chi-
osan oligosaccharide coated iron oxide nanoparticles were
ynthesized and characterized by transmission electron
icroscopy (TEM), Fourier transform infrared (FTIR) spec-
roscopy, X-ray diffraction (XRD), zeta potential analysis
nd physical property measurement system (PPMS). There-
fter, comparative toxicity assessment of nanoparticles
INPs and CSO-INPs) was  performed on three cell lines
HeLa, A549 and Hek293) by MTT  assay (cell viability). We
hen evaluated the toxicity mechanism of nanoparticles
nd inferred the inﬂuence of surface engineering on cell
oxicity by various cytotoxic assays: phosphatidylserine
xclusion assay (mitochondria membrane integrity), JC-1
robe staining (mitochondria membrane potential), DCFH-
A assay (estimation of ROS generation) and DHE assay
DNA degradation estimation). Along with above explained
ssays, morphological changes in cellular targets were cor-
oborated by Acridine orange/ethidium bromide double
taining and electron microscopy.
. Materials and methods
.1. ChemicalsAnalytical grade chemicals, iron (III) chloride (97%),
leic acid (90%), n-hexane (95%), anhydrous ethanol,
-octadecene (90%), acetic acid, 1-ethyl-3-(3-dimethy-
amino-propyl)-N-ethylcarbodiimide hydrochloride (EDC)Fig. 4. Hysteresis loop of iron oxide nanoparticles (INPs) at 300 K (a).
Chitosan oligosaccharide coated iron oxide nanoparticles (CSO-INPs) (b).
(commercial grade), N-hydroxy-succinimide (NHS), chi-
tosan oligosaccharide (Mn  5000 and >90% deacetylated),
JC-1 (5,5,6,6-tetrachloro-1,1,3,3-tetraethyl-benzimidazo-
lylcarbocyanineiodide), dihydrochloroﬂuorescein-diacet-
ate (DCFH-DA) and dihydroethidine (DHE), Annexin
V-FITC, ethidium bromide and trypsin–EDTA (ethylene-
diamine tetra acetic acid) were purchased from
Sigma–Aldrich. N-[(3-trimethoxysilyl) propyl] EDTA
trisodium salt (50% in water) was  received from Gelest Inc.,
U.S.A. The water used throughout this work was of reagent
grade produced by a Milli-Q water puriﬁcation system.
DMEM (Dulbecco’s modiﬁed Eagle’s medium), FBS (foetal
bovine serum) and PenStrep (penicillin–streptomycin)
were purchased from Biological Industries Inc.
2.2. Synthesis of nanoparticles
2.2.1. Synthesis of iron oxide nanoparticles (INPs)
Fe3O4 nanoparticles were synthesized as described by
Jana et al. [20] with slight modiﬁcations. In a typical
synthesis of iron–oleate complex, 2.55 g of iron chloride
(FeCl3.6H2O) was dissolved in 100 ml  of methanol and
11 ml  of oleic acid under continuous stirring. Another solu-
tion prepared by dissolving 1.6 g of NaOH in 200 ml  of
methanol was  added to the above solution in stirring con-
dition. The observed brown precipitate of iron oleate was
washed with methanol and dried under vacuum overnight
to remove the solvent. 4.02 g of synthesized solid mass was
dissolved in 30 ml  of 1-octadecene at 70 ◦C to make stock
solution. Thereafter, 10 ml  of stock solution was  mixed with
40 ml  of 1-octadecene and 0.1 equiv. of oleic acid and the
solution was heated to 280 ◦C for 30 min  in an inert envi-
ronment. When the reaction was complete, the mixture
was precipitated twice with ethanol. Resulting precipitate
was re-dispersed in hexane for further use.
2.2.2. Synthesis of chitosan oligosaccharide linked iron
oxide nanoparticles (CSO-INPs)Synthesized nanoparticles are stable in nonpolar sol-
vents (such as hexane) and capped with nonpolar end
groups on their surface. Oleic acid is widely used in
the synthesis of iron oxide nanoparticles because it can
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Fig. 6. Representation of cytotoxicity of iron oxide nanoparticles (INPs)
and chitosan oligosaccharide coated iron oxide nanoparticles (CSO-INPs)
in  HeLa, A549 and Hek293 cells, with different concentrations at various
with different concentrations (0.5, 2, 4 g/l)  of INPs andFig. 5. Zeta potential measurement of iron oxide nanoparticles (a). Chi-
tosan oligosaccharide coated iron oxide nanoparticles (b) at pH 3, 7 and
9.
form a dense protective monolayer, thereby, producing
highly uniform and monodisperse particles [6]. For the
synthesis of iron oxide nanoparticles (INPs) suitable for
biological applications, the hydrophobic surfactant coat-
ing needs to be replaced by a hydrophilic, biocompatible,
and functional coating that allows controlled interaction
of nanoparticles with biological species. The oleic acid on
the particle surface was replaced with a COOH contain-
ing silane using a method reported by Palma et al. [21].
Once functionalized with a carboxylic group, nanoparticles
were further functionalized using chitosan oligosaccha-
ride method developed by López-Cruz et al. [22]. Amino
group of chitosan oligosaccharide was covalently bonded
with terminal carboxylic group of silane functionalized iron
oxide nanoparticles through carbodiimide activation by the
reaction of EDC and NHS [23].
2.2.3. Characterization of chitosan linked iron oxide
nanoparticles (CSO-INPs)
TEM images were recorded on a JEOL 2100F TEM, oper-
ated at an accelerating voltage of 200 kV. Samples were
prepared by adding 10 l of the nanoparticles solution on
200-mesh carbon coated Cu grids. For the rapid counting
of nanoparticles, TEM images were further processed by
NIH Image J software [24]. Powder X-ray diffraction (XRD)
studies were carried out through a Philips1820 advance
diffractometer equipped with Ni-ﬁltered Cu K radiation
maintaining the scan rate of 0.24◦ per minute. Fourier
transform infrared (FTIR) spectroscopy studies were car-
ried out by Varian 7000 FTIR to determine the chemical
functional groups in the nanoparticles at various steps of
synthesis.
FTIR spectra were recorded in the range of
500–4000 cm−1 with an average of 16 scans per sam-
ple. Physical property measurement system (PPMS,
Cryogenic PT 415) magnetometer was used to measure
the magnetization of synthesized nanoparticles. A known
amount of the dry powder of nanoparticles was loaded
in sample capsule and suspended in magnetometer.time intervals. Statistical analysis was performed by Student’s t-test fol-
lowed by three independent experiments, the statistical signiﬁcance of
INPs shown in error bars represents the standard error mean, *p < 0.05.
Magnetization of sample was  measured with respect to
variable magnetic ﬁeld −0.7 T to +0.7 T at 300 K.
2.3. In vitro toxicity studies
2.3.1. Cell culture and maintenance
HeLa cells (human cervix carcinoma,) A549 cells
(human lung carcinoma) and HeK293 (human embryonic
kidney) cells were obtained from NCCS (National Centre for
Cell Sciences, Pune, India). These cell lines were grown in
high glucose DMEM with 50 mM glutamine, supplemented
with 10% FBS, 100 U/ml penicillin and 100 mg/ml strep-
tomycin. Cells were maintained in a humidiﬁed 5% CO2
incubator at 37 ◦C.
2.3.2. MTT  assay for cytotoxicity
HeLa (human cervix carcinoma), A549 (human lung car-
cinoma) and Hek293 (human embryonic kidney) cells were
seeded in 96-well plates at the density of 1 × 105 cells/well
in DMEM media supplemented with 10% FBS. Cells were
incubated at 37 ◦C in 5% CO2 incubator. Cells were treatedCSO-INPs respectively for 24, 48 and 72 h at 37 ◦C. 10 l of
MTT  (prepared in 1× PBS buffer) from 5 mg/ml  stock was
added in each well and incubated at 37 ◦C for 4 h in dark.
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Fig. 7. Acridine orange/ethidium bromide double staining for apoptosis analysis in Hek293, A549 and HeLa cells after iron oxide nanoparticles and chitosan
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he formazan crystals were dissolved using 100 l of DMSO
25]. Further, the amount of formazan crystal formation
as measured as difference in absorbance by Bio-Red 840
LISA reader at 570 nm and 690 nm reference wavelength.
.3.3. Acridine orange/ethidium bromide doubles
taining (AO/EB) assay
HeLa, A549 and Hek293 (1 × 105 cells/well) cells were
rown on cover slips and treated with 4 g/l  iron oxide
anoparticles (INPs) and chitosan oligosaccharide coated
ron oxide nanoparticles (CSO-INPs) respectively. Cells
ere incubated in CO2 incubator at 37 ◦C for 48 h. Cells
ere washed with 1× PBS buffer (pH 7.4), ﬁxed with abso-
ute methanol for 10 min, and washed again with 1× PBS
uffer (pH7.4). Now, cells were stained with 1 l of AO/EB
ocktail (AO/EB 100 g/ml) for 10–15 min, cells were then
mmediately washed with phosphate buffer, followed by
maging using ﬂuorescence microscope [26].
.3.4. Mitochondria deformation evaluation by
ransmission electron microscope (TEM)
For the mitochondria morphological alteration analy-
is, HeLa, A549 and Hek293 cells (1 × 105 cells/well) were
reated with 4 g/l  iron oxide nanoparticles and chitosan
ligosaccharide coated iron oxide nanoparticles (CSO-
NPs) respectively for 48 h. Cells were trypsinized withat 48 h (UT = untreated, CSO-INPs = chitosan oligosaccharide linked iron
tosis cells, LAC = late apoptosis cells).
1× trypsin–EDTA followed by centrifugation and ﬁxation
with 2% glutaraldehyde in 0.1 sodium cacodylate for 1 h at
4 ◦C. Cells were washed twice with 0.1 M sodium cacody-
late (pH 7.4) and ﬁxed with 2% osmium tetroxide in 0.1 M
sodium cacodylate for 1 h at room temperature. Cells were
washed again with 1× PBS buffer (pH 7.4). Cells were
treated with 1% uranyl acetate for 1 h and washed with 1×
PBS buffer (pH 7.4) twice. After ﬁxing and sectioning, cells
were dehydrated via ethanol and stained with 5% uranyl
acetate for 30 min  followed by Reynold’s lead citrate incu-
bation [27]. Stained cells were examined under JEOL 2100F
transmission electron microscope. The presence of INPs
and CSO-INPs in mitochondria surface and matrix was fur-
ther conﬁrmed by the TEM-EDS elemental analysis (TEM,
JEOL 2100F).
2.3.5. Detection of mitochondria membrane integrity
For apoptosis analysis HeLa, A549 and Hek293 cells
were seeded at the density of 1 × 105 cells/well and incu-
bated at 37 ◦C for 24 h. Cells were treated with 4 g/l
of INPs and CSO-INPs respectively for 48 h. Cells were
trypsinized using 1× trypsin–EDTA and pooled in 1.5 ml
tube, washed with 1× PBS buffer. Cells were resuspended
in 500 l of 1× Annexin binding buffer [10× buffer com-
position: 0.1 M Hepes/NaOH (pH 7.4), 1.4 M NaCl, 25 mM
CaCl2], 1 l of Annexin V-FITC reagent used from stock
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Fig. 8. Morphological alteration of mitochondria after iron oxide nanoparticles (INPs) and chitosan oligosaccharide coated iron oxide nanoparticles (CSO-
= untrea
r mitocINPs)  treatment in Hek293, A549 and HeLa cells with 4 g/l  at 48 h (UT 
INPs  = iron oxide nanoparticles, NM = normal mitochondria, VM = vesicula
(ﬁnal concentration 1 g/ml). Stained samples were gently
mixed and incubated at 37 ◦C for 10–20 min  in dark [28].
FL1 channel was applied for detecting Annexin V-FITC
staining through ﬂow cytometry (BD Biosciences) with
excitation wavelength 488 nm.  Fluorescence spectra were
analyzed by FCS 4 Express Flow Cytometry software.
2.3.6. Estimation of mitochondrial membrane potential
Mitochondrial membrane potential was analyzed
by JC-1 probe (5,5,6,6-tetrachloro-1,1,3,3-tetraethyl-
benzimidazolylcarbocyanine iodide) staining [29,30].
HeLa, A549 and Hek293 cells (1 × 105 cells/well) were
harvested after 48 h exposure of 4 g/l  iron oxide
nanoparticles and chitosan oligosaccharide coated iron
oxide nanoparticles (CSO-INPs) and centrifuged at 400 × g
for 5 min. Cell pellet was resuspended in 0.5 ml  of JC-1
solution (10 g/ml) for 10 min. Cells were washed with
1× PBS buffer. Mitochondrial depolarization is identiﬁed
by reduction of the red/green ﬂuorescence ratio. Green
ﬂuorescence (monomers) was observed through FL1
channel with almost 10,000 events of each sample using
ﬂow cytometry (BD Biosciences) with excitation at 488 nm
wavelength. Fluorescence spectra were analyzed by FCS 4
Express Flow Cytometry software.ted, CSO-INPs = chitosan oligosaccharide linked iron oxide nanoparticles,
hondria, DMM = disintegrated mitochondrial membrane).
2.3.7. Measurement of reactive oxygen species (ROS) by
DCFH-DA
Analysis of ROS production was  carried out using the
method reported by Mancini et al. [31], with slight modi-
ﬁcation. HeLa, A549 and Hek293 cells (1 × 105 cells/well)
were seeded and incubated at 37 ◦C in CO2 incubator
for 24 h. The cells were treated with 4 g/l  iron oxide
nanoparticles (INPs) and chitosan oligosaccharide coated
iron oxide nanoparticles (CSO-INPs) respectively for 48 h.
Cells were trypsinized with 1× trypsin–EDTA, and cen-
trifuged at 1000 rpm for 5 min. Cells were washed twice
with 1× PBS buffer (pH 7.4) followed by 1 h incubation
in DCFH-DA (10 mol/l) in FBS-free DMEM medium. Cells
were resuspended in 1× PBS buffer, subjected to ﬂow
cytometry analysis. Finally, ﬂuorescence spectrum was
measured by ﬂow cytometry (BD Biosciences) at 488 nm
excitation and emission at 530 nm wavelength for DCFDA
with 10,000 events of each sample. Fluorescence spectra
were analyzed by FCS 4 Express Flow Cytometry software.
2.3.8. Measurement of reactive oxygen species (ROS)
production by DHE
For further evaluation of ROS production, HeLa, A549
and Hek293 cells (1 × 105 cells/well) were seeded into 24-
well plates and allowed to adhere in 24 h. After 24 h,
S. Shukla et al. / Toxicology Reports 2 (2015) 27–39 33
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Sig. 9. Phosphatidylserine exclusion illustration by Annexin-V-FITC after
anoparticles (CSO-INPs) treatment in Hek293, A549 and HeLa cells with
xide  nanoparticles, INPs = iron oxide nanoparticles).
resh media was supplemented with 4 g/l  iron oxide
anoparticles and chitosan oligosaccharide coated iron
xide nanoparticles (CSO-INPs) respectively. Cells were
rypsinized with 1× trypsin–EDTA, and centrifuged at
000 rpm for 5 min. Cells were washed twice with 1× PBS
uffer. Cells were re-suspended in HBSS (Hanks’ balanced
alt solution) buffer containing the ﬂuorescence probes
HE (2.5 M).  Cells were incubated at 37 ◦C for 20–30 min
n dark and washed with 1× PBS buffer [29]. Finally, ﬂuo-
escence spectrum was measured by ﬂow cytometry (BD
iosciences) at 488 nm excitation and emission at 620 nm
avelength with 10,000 events of each sample. Fluo-
escence spectra were analyzed by FCS 4 Express Flow
ytometry software.
.4. Statistical analysisSigniﬁcance of the toxicity of iron oxide nanoparti-
les (INPs) and chitosan oligosaccharide coated iron oxide
anoparticles (CSO-INPs) in MTT  assay was analyzed by
tudent’s t-test. Each experiment, with six in replicates,ide nanoparticles (INPs) and chitosan oligosaccharide coated iron oxide
l at 48 h (UT = untreated, CSO-INPs = chitosan oligosaccharide linked iron
was performed in at least three independent cell culture
preparations. The t-test was  used to evaluate the difference
in means between groups with a conventional threshold
p-value for statistical signiﬁcance deﬁned as *p < 0.05.
3. Results
3.1. Characterization of synthesized INPs and CSO-INPs
Synthesized Fe3O4 nanoparticles were found to be
monodisperse and spherical in shape having a mean
diameter of 6 ± 1.2 nm in Fig. 1(a). The TEM image of Fe3O4-
chitosan nanoparticles (CSO-INPs) has been shown in
Fig. 1(b). The structures of chitosan oligosaccharide coated
iron oxide nanoparticles were observed bigger in size with
a mean diameter of 8 ± 2.7 nm. TEM image clearly indicates
that the surface modiﬁcation process did not cause signif-
icant change in the size of the particles. However, a little
aggregation was  observed in the Fe3O4-CSO nanoparticles,
this may  be due to higher molecular weight of chitosan
oligosaccharide used for the synthesis [22,32,33]. Fig. 2(a)
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Fig. 10. Mitochondrial membrane potential determination by JC-1 probe after iron oxide nanoparticles (INPs) and chitosan oligosaccharide coated iron
 with 4 oxide nanoparticles (CSO-INPs) treatment in Hek293, A549 and HeLa cells
iron  oxide nanoparticles, INPs = iron oxide nanoparticles).
shows X-ray diffraction (XRD) pattern of synthesized iron
nanoparticles exhibiting peaks at 2 at 30.1, 35.5, 42.6,
53.6, 57.0 and 62.8 which can be assigned to diffraction of
the (2 2 0), (3 1 1), (4 0 0), (4 2 2), (5 1 1), and (4 4 0) planes,
respectively of spinal structured magnetite nanoparticles
(JCPDS card no. 82-1533). It is to be noted that the coating
process did not result in the phase change of Fe3O4. The
broad reﬂection planes can be attributed to the nanosize
of the iron oxide nanoparticles [34]. The XRD pattern CSO-
INPs exhibited its two characteristic peaks at 2 = 20.1, 30.1,
35.5 and 62.8 in Fig. 2(b). Presence of characteristic peak at
2 = 20.1 for chitosan oligosaccharide along with 2 = 30.1,
35.5 and 62.8 associated with the iron oxide nanoparticles
conﬁrms the coating of chitosan oligosaccharide on iron
oxide nanoparticles [8,35].FTIR graph indicates the characteristic peaks of oleic
acid coated iron oxide nanoparticles in Fig. 3(a). The
CH2 stretch is seen at 2846 cm−1 and 2924 cm−1, C C at
1645 cm−1, and CH3 stretching at 1462 cm−1, indicatingg/l at 48 h (UT = untreated, CSO-INPs = chitosan oligosaccharide linked
the presence of oleic acid on nanoparticles surface. Suc-
cessful amide formation between amine groups in CSO
and the carboxylic group of silane was  conﬁrmed by
the appearance of characteristic bands such as OH
group at 3352 cm−1, C O (secondary amide formation) at
1635 cm−1 and C O C at 1095 cm−1, for CSO in Fig. 3(b)
[8,22,23,35].
PPMS magnetometer results showed magnetization
properties as a function of applied ﬁeld at 300 K obtained
for dry powders of iron oxide nanoparticles and CSO
coated iron oxide nanoparticles. The results indicate super-
paramagnetic behaviour of synthesized nanoparticles, that
is, net magnetization of the particles in the absence of an
external magnetic ﬁeld was found to be zero [6]. Fig. 4
shows that the saturation magnetization of the CSO coated
sample (12 emu  per g) is lower than that of the iron
nanoparticles (32 emu  per g).
Zeta potential data in Fig. 5(a) shows the zeta poten-
tial of INPs coated with silane COOH. The particles consist
S. Shukla et al. / Toxicology Reports 2 (2015) 27–39 35
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aig. 11. ROS estimation by dihydrochloroﬂuorescein-diacetate (DCFH-DA
ligosaccharide coated iron oxide nanoparticles (CSO-INP) treatment with
xide  nanoparticles, INPs = iron oxide nanoparticles).
f zeta potential −1.9, −36.5 and −51 mV  at pH 3, 7 and 9
espectively, which may  be attributed to negative charge
n surface of nanoparticles due to the presence of COOH
roup of oleic acid and carboxylic silane surface coating.
eta potential data in Fig. 5(b) indicates that CSO-INPs were
ositively charged with a surface potential greater than
37 mV  at pH 3. This conﬁrms the presence of amino groups
n the nanoparticle surface in their protonated form, and
hus establishing the presence of chitosan oligosaccha-
ide on the particle surface. Results indicate that with an
ncrease of pH, the surface charge of the particle decreased
hich was probably due to the deprotonation tendency of
he surface exposed amino groups at higher values of pH
22]. Fig. 5(b) also shows that particles possess positive zeta
otential of +11 mV  at pH 7, which corresponds to the pH of
atural water. However, at pH 9, particles show a negative
eta potential of −2.8 mV.
These results conﬁrm that the nanoparticles have suf-
cient colloidal stability which is necessary for biological
nd environmental applications [8].93, A549 and HeLa cells after ironoxide nanoparticles (INPs) and chitosan
l at 48 h (UT = untreated, CSO-INPs = chitosan oligosaccharide linked iron
3.2. Toxicity analysis of synthesized INPs and CSO-INPs
3.2.1. MTT assay for cytotoxicity analysis
MTT  (3-(4,5-dimethylthiazol-2yl)-2,5-
diphenyltetrazolium) assay for viability of various cell
lines was performed. The assay is based on reduction of
soluble yellow tetrazolium into insoluble purple formazan
crystals by mitochondrial succinate dehydrogenase of
viable cell. Therefore, the rate of formazan crystal for-
mation is directly proportional to number of viable cells
which is measured in terms of absorbance [25]. The results
in Fig. 6 clearly indicate that the toxic effect of CSO-INPs on
A549 and HeLa cells were moderate as compared to bare
INPs treatment. Higher toxicity of iron oxide nanoparticles
could be attributed to high release of iron ions in intra-
cellular space and in situ degradation [19]. This toxicity of
nanoparticles was found to be time and dose dependent.
Results clearly indicate that the cell viability decreased
with increase in dose and time. In case of Hek293 cells
iron oxide nanoparticles lead to toxic effects whereas,
36 S. Shukla et al. / Toxicology Reports 2 (2015) 27–39
racellulFig. 12. Schematic representation of int
CSO-INPs did not cause any signiﬁcant toxicity. All ﬁndings
clearly suggest that the chitosan oligosaccharide coating
reduces the toxic effects of INPs. Less toxicity of CSO-INPs
may  be attributed to controlled release of Fe2+ ions, which
trigger the ROS mediated cell death [17,19].
3.2.2. Morphological alteration analysis by AO/EB
staining and TEM
To compare the apoptotic effects on non-cancerous and
cancer cell lines, cells were subjected to INPs and CSO-INPs
treatment followed by Acridine orange/ethidium bromide
double staining (AO/EB). Acridine orange dye stains both
live and dead cells. While ethidium bromide, a DNA bind-
ing dye, stains those cells that have lost nuclear membrane
integrity. Mixture of both dyes is commonly used to visu-
alize nuclear membrane disintegration and apoptotic body
formation that are characteristic of apoptosis. Three kinds
of cells were observed as per the ﬂuorescence emission
spectra. (i) Normal cells appeared in organized structure
with an intact nuclei stained with green ﬂuorescence. (ii)
Early apoptotic cells were visible with bright green and
light orange patches; and (iii) Late apoptotic cells which
were stained with orange to red patches [26]. After treat-
ment with iron oxide nanoparticles, cells exhibit orange
colour with some patches of red, indicating early and late
phase of apoptosis whereas, this kind of colour distribu-
tion was rarely seen in chitosan oligosaccharide coated
iron oxide nanoparticles (CSO-INPs) treated cells in Fig. 7.ar uptake pathways and targets of INPs.
The results revealed that CSO-INPs caused less apopto-
sis in healthy as well as cancer cell lines as compared to
uncoated/bare INPs.
TEM image in Fig. 8 suggests that the INPs treatment
induces remodelling of inner mitochondrial membrane
and subsequent lost of membrane integrity of mito-
chondria in HeLa and A549 cells. Moreover, moderate
alternation was  observed in case of Hek293 cells. TEM
images clearly indicate that the CSO-INPs cause moderate
deformation in mitochondria compared to INPs treat-
ment. As we know mitochondria of healthy cells have
intact outer membrane and organized cristae as com-
pared to the cells undergoing apoptosis, while alteration in
mitochondria appears during late apoptosis phase and is
generated due to loss of mitochondrial membrane poten-
tial and release of cytochrome c resulting to expansion
of mitochondrial matrix and ruptured outer membrane
[27].
Results of TEM-EDX elemental analysis of INPs treated
cells clearly demonstrate the prominent presence of ele-
mental iron, silicon and oxygen (components of INPs)
in mitochondrial membrane as well as in mitochondrial
matrix (Supplementary Fig. S1). In contrast, elemental
analysis of CSO-INPs treated mitochondria shows the pres-
ence of lesser amount of iron with nitrogen, silica and
oxygen (component of CSO-INPs) (Supplementary Fig. S2).
These ﬁndings clearly indicate the controlled release of iron
ion by the chitosan oligosaccharide coating of CSO-INPs,
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herefore, inducing lesser cellular toxicity in the case of
SO-INPs treated cells.
.3. Assessment of apoptosis pathway
.3.1. Evaluation of mitochondria membrane integrity
Apoptosis is responsible for multiple alterations
n mitochondrial membrane. During apoptosis, mito-
hondrial phosphatidylserine is externalized from inner
urface to the outer surface. Apoptosis is measured
n terms of binding of externalized phosphatidylserine
o phospholipid binding protein Annexin V conju-
ated with ﬂuorochromes [28]. Fig. 9 shows that the
SO-INPs treatment causes moderated disintegration in
itochondrial membranes of HeLa, A549 and Hek293
ells as compared to the bare INPs. This data high-
ights the fact that chitosan coating of iron oxide
anoparticles reduces its apoptotic triggering effects
hrough lesser disintegration of mitochondrial membrane
ntegrity.
.3.2. Mitochondrial membrane potential analysis
The loss of mitochondrial membrane potential, a dis-
inctive feature of apoptotic cell, is analysed by cationic
arbocyanine dye JC-1. In a normal cell, JC-1 dye is
resent in monomeric form in cytosol and emits green
uorescence, and accumulate as aggregates in mitochon-
ria emitting red ﬂuorescence. Whereas in mitochondrial
embrane disintegrated apoptotic cell, JC-1 retains its
onomeric form in mitochondria and emits green ﬂuores-
ence only [29,30].
Treatment of iron oxide nanoparticles progressively
issociates mitochondrial potential and increases JC-1
reen ﬂuorescence without a corresponding increase in
C-1 red ﬂuorescence in HeLa, A549 and Hek293 cells,
hereas moderate JC-1 red ﬂuorescence was observed
n CSO-NPs treated cells in Fig. 10. Thus results sug-
est that the formation of monomer of JC-1 is high in
ron oxide nanoparticles treated HeLa, A549 and Hek293
ells, with respect to CSO-NPs indicating that INPs toxicity
ay  be reduced due to coating of chitosan oligosaccha-
ide.
.3.3. Analysis of ROS generation by
ihydrochloroﬂuorescein-diacetate (DCFH-DA) and
ihydroethidine (DHE)
DCFH-DA assay for ROS generation analysis revealed
hat Dichloroﬂuorescein (DCF) production is high in iron
xide nanoparticles treated Hek293, A549 and HeLa cells
ith respect to CSO-INPs treated cells in Fig. 11. Produc-
ion of highly ﬂuorescent DCF in INPs treated cells may
e attributed to the oxidation of non-polar dye DCFH-DA
y apoptosis induced intracellular ROS and other per-
xides. In a non-apoptotic cell DCFH-DA converts to its
on-ﬂuorescent, non-polar derivative DCFH by the action
f cellular esterase [36].
Dihydroethidine (HE) probe is oxidized into red ﬂuores-
ent product ethidium in the presence of superoxide anion.
his action has been associated with mitochondrial uncou-
ling and increased ROS production [31]. Interaction of
thidium to DNA is inferred with higher red ﬂuorescence inports 2 (2015) 27–39 37
INPs treated cell compared to CSO-INPs treated HeLa, A549
and Hek293 cells in Fig. S3 (Supplementary data). This ﬁnd-
ing also demonstrates that the ROS production increases in
dose and time-dependent manner after treatment of iron
oxide nanoparticles and chitosan oligosaccharide coated
iron oxide nanoparticles (CSO-INPs).
Therefore, this correlation is maintained with JC-1
monomer formation and continuous enhancement of ROS
production, these features are indicators of programmed
cell death [37]. The conclusion of this study strongly cor-
roborates that the toxicity effect of CSO-INPs was probably
reduced due to covering of chitosan oligosaccharide on bare
iron oxide nanoparticles.
The ﬁndings of the present study also indicate the prob-
able mechanism of nanoparticles interaction with various
cellular targets resulting in cytotoxicity and it also corrob-
orates with the earlier established hypothesis in Fig. 12
[15–17,19,38].
It is hypothesized that internalized nanoparticles
release ferrous form of iron ion after the enzymatic degra-
dation of INPs into the acidic environment of lysosome.
Ferrous ion could react with hydrogen peroxide generated
in the mitochondria and induces the generation of highly
reactive oxygen species as hydroxyl radicals through the
Fenton reaction [16,19,38,39]. Induced ROS further causes
the inﬂammation in the cell, interfering mitochondrial
function and release of cytochrome c by altered mem-
brane potential which ultimately triggers the apoptosis
[37].
Findings of the current study indicate that surface
engineering of iron oxide nanoparticles with chitosan
oligosaccharide reduces cytotoxicity of bare iron oxide
nanoparticles. Our results indicate that the chitosan
oligosaccharide coating on INPs results in the decrease in
cellular damage including lesser damage to mitochondrial
membrane and moderate ROS production. The reduced
toxicity of INPs after the coating of polycationic chitosan
oligosaccharide may  be attributed to controlled release
of Fe2+ ion from nanoparticles into acidic environment of
lysosomes, which is a key factor in the toxicity determina-
tion [17,40,41].
4. Conclusion
Iron oxide nanoparticles (INPs) and chitosan oligosac-
charide linked iron oxide nanoparticles (CSO-INPs) were
synthesized for evaluation of their in vitro toxicity. Syn-
thesized iron oxide nanoparticles were found to be well
dispersed and non-agglomerative. 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay along
with ﬂow cytometry study for cell viability, membrane
integrity, mitochondrial membrane potential (MMP), and
reactive oxygen species (ROS) assays clearly indicated the
toxicity potential of INPs. Coating of these INPs with bio-
compatible chitosan oligosaccharide not only makes theseof pH but less toxic also. Present study also suggests the
need of comprehensive in vivo toxicity assessment for the
critical dose evaluation of surface engineered iron oxide
nanoparticles.
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